Atlantic Technology Ventures, Inc., Delisted From the Nasdaq.

Business Editors

NEW YORK--(BUSINESS WIRE)--Aug. 23, 2001

Atlantic Technology Ventures, Inc., (Nasdaq: ATLC) common stock, previously trading on the Nasdaq Small Cap Market under the symbol ATLC, has, pursuant to the decision of the Nasdaq Listing Qualification Panel, been delisted from the Nasdaq Small Cap Market as of the open of business on August 23, 2001.

On March 22, 2001 the Staff of the Nasdaq Stock Market notified Atlantic that it has failed to demonstrate a closing bid price of at least $1.00 per share for 30 consecutive trading days and was in violation of Nasdaq Market Place Rule 4310(c)(4). In accordance with applicable Nasdaq Marketplace rules, Atlantic was provided a 90-day grace period, through June 20, 2001, during which to regain compliance. On June 27,2001, Atlantic requested a hearing, which effectively stayed the delisting. However, after submission of materials in support of Atlantic's position to the panel, the panel has informed Atlantic that its common stock will be delisted.

The NASD has informed Atlantic that Atlantic's common stock will be eligible to trade on the OTC Bulletin Board under the same symbol. Shareholders will still be able to get current trading information, including the last trade bid and ask quotations and share volume.

About Atlantic Technology Ventures

Atlantic Technology Ventures, Inc. is a publicly held venture capital company specializing in early-stage, breakthrough technologies and rapidly incubating these through a definitive proof-of-principle. Atlantic currently has investments in: Catarex, a device for cataract removal; CT-3, a synthetic derivative of marijuana for treating pain and inflammation; and superconducting electronics for telecommunications.

Safe Harbor Statement

Cautionary statement under the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995: This press release contains certain forward-looking statements that relate to future scientific, business and financial performance. These statements are only predictions and are subject to a number of risks and uncertainties that may cause the actual events or results to differ from those discussed or implied in these statements. These risks and uncertainties include competition from other manufacturers of related technologies, the unavailability of any necessary intellectual property rights possessed by third parties, and certain of those risks described in Atlantic's most recent report on Form 10-KSB with the Securities and Exchange Commission.